Inspiratory Muscle Training in Patients With Inflammatory Myopathy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorJózef Piłsudski University of Physical Education

About this trial

Inflammatory myopathies are rare autoimmune diseases leading to progressive muscle weakness, often including the respiratory muscles. This study aims to investigate whether inspiratory muscle training (IMT) using a threshold device can improve functional status in patients with inflammatory myopathy. Thirty-three patients will undergo a 3-month home-based IMT program with progressive resistance. Functional capacity, inspiratory muscle strength, lung function, diaphragmatic mobility, fatigue, and quality of life will be assessed at baseline and during follow-up. The primary hypothesis is that IMT will enhance inspiratory muscle strength and translate into better functional performance and quality of life.

Eligibility criteria

Qualifiers

Diagnosis of inflammatory myopathy according to European Alliance of Associations for Rheumatology / American College of Rheumatology criteria

Age ≥ 18 years

Stable clinical condition allowing participation in physical activity

Ability to understand and follow instructions

Disqualifiers

Cognitive impairment preventing proper exercise performance

Current respiratory tract infection

Previous respiratory muscle training within the last 12 months

History of spontaneous pneumothorax

Trial design

Treatments tested in this trial

  • Inspiratory Muscle Training (IMT)

Treatment groups

33 Participants
are divided into 1 treatment group